Evidence map›Paper›PMID 38269203›Full record

ReviewIranian journal of biotechnology2023

A Comprehensive Review of the Key Characteristics of the Genus

Shirin Yousefian, Fazileh Esmaeili, Tahmineh Lohrasebi

Open access · greenAbstract readReview
In one paragraph

Review in Iranian journal of biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Integrated Evaluation ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Space-flown spearmint (Frontiers in plant science · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Investigating the Health Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shirin YousefianDepartment of Plant Bioproducts, National Institude of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Fazileh EsmaeiliDepartment of Plant Bioproducts, National Institude of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Tahmineh LohrasebiDepartment of Plant Bioproducts, National Institude of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
National Institute of Genetic Engineering and Biotechnology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: The genus Evidence Acquisition: The current review is written based on scientific literature obtained from online databases, including Google Scholar, PubMed, Scopus, and Web of Science regarding the characteristic features of some species of the genus Results: In this article, we offer an overview of the key characteristics, natural compounds, biological properties, and medicinal uses of the genus

Indexed as

Bioactive compoundLamiaceaeMenthaSecondary metabolite

Identifiers

PMID38269203
PMCPMC10804064
OpenAlexW4391233083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.